Rise Advisors’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.68K | Hold |
991
| – | – | ﹤0.01% | 1149 |
|
|
2025
Q1 | $8.09K | Buy |
991
+933
| +1,609% | +$7.61K | ﹤0.01% | 1106 |
|
|
2024
Q4 | $546 | Hold |
58
| – | – | ﹤0.01% | 1096 |
|
|
2024
Q3 | $619 | Hold |
58
| – | – | ﹤0.01% | 1186 |
|
|
2024
Q2 | $575 | Hold |
58
| – | – | ﹤0.01% | 1186 |
|
|
2024
Q1 | $683 | Hold |
58
| – | – | ﹤0.01% | 1202 |
|
|
2023
Q4 | $823 | Hold |
58
| – | – | ﹤0.01% | 537 |
|
|
2023
Q3 | $705 | Hold |
58
| – | – | ﹤0.01% | 562 |
|
|
2023
Q2 | $728 | Hold |
58
| – | – | ﹤0.01% | 595 |
|
|
2023
Q1 | $643 | Hold |
58
| – | – | ﹤0.01% | 711 |
|
|
2022
Q4 | $708 | Hold |
58
| – | – | ﹤0.01% | 686 |
|
|
2022
Q3 | $1K | Hold |
58
| – | – | ﹤0.01% | 627 |
|
|
2022
Q2 | $1K | Hold |
58
| – | – | ﹤0.01% | 633 |
|
|
2022
Q1 | $1K | Hold |
58
| – | – | ﹤0.01% | 601 |
|
|
2021
Q4 | $670 | Buy |
+58
| New | +$670 | ﹤0.01% | 614 |
|